Literature DB >> 24493470

Neuropathic pain in neuromyelitis optica affects activities of daily living and quality of life.

Sizheng Zhao1, Kerry Mutch2, Liene Elsone2, Turo Nurmikko2, Anu Jacob2.   

Abstract

Though pain in neuromyelitis optica (NMO) has been described in two recent reports, the proportion with true neuropathic pain (NP), its features, impact on activities of daily living (ADL) and quality of life has not been well characterised. A cross-sectional study of 50 NMO patients with transverse myelitis was performed using Douleur Neuropathique 4, Brief Pain Inventory, Extended Disability Status Scale and Short Form 36. NP was identified in 62% of patients. Pain was constant in 68% affecting most ADL. Pain was associated with significant reduction of the SF36 Mental Composite Score. The high prevalence of NP and associated disability necessitates an in-depth enquiry in patients with NMO.
© The Author(s) 2014.

Entities:  

Keywords:  Neuromyelitis optica; SF36; aquaporin 4; brief pain inventory; demyelinating; neuropathic pain; pain; quality of life

Mesh:

Substances:

Year:  2014        PMID: 24493470     DOI: 10.1177/1352458514522103

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  24 in total

Review 1.  Review of Treatment for Central Spinal Neuropathic Pain and Its Effect on Quality of Life: Implications for Neuromyelitis Optica Spectrum Disorder.

Authors:  Maureen A Mealy; Sharon L Kozachik; Michael Levy
Journal:  Pain Manag Nurs       Date:  2019-05-15       Impact factor: 1.929

Review 2.  Headache in Neuromyelitis Optica.

Authors:  Alina Masters-Israilov; Matthew S Robbins
Journal:  Curr Pain Headache Rep       Date:  2017-04

Review 3.  Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later.

Authors:  Sean J Pittock; Claudia F Lucchinetti
Journal:  Ann N Y Acad Sci       Date:  2015-06-10       Impact factor: 5.691

Review 4.  [Optical coherence tomography in neuromyelitis optica spectrum disorders].

Authors:  F C Oertel; H Zimmermann; A U Brandt; F Paul
Journal:  Nervenarzt       Date:  2017-12       Impact factor: 1.214

5.  Scrambler therapy improves pain in neuromyelitis optica: A randomized controlled trial.

Authors:  Maureen A Mealy; Sharon L Kozachik; Lawrence J Cook; Lauren Totonis; Ruth Andrea Salazar; Jerilyn K Allen; Marie T Nolan; Thomas J Smith; Michael Levy
Journal:  Neurology       Date:  2020-04-08       Impact factor: 9.910

Review 6.  What's new in neuromyelitis optica? A short review for the clinical neurologist.

Authors:  Daniel Whittam; Martin Wilson; Shahd Hamid; Geoff Keir; Maneesh Bhojak; Anu Jacob
Journal:  J Neurol       Date:  2017-03-13       Impact factor: 4.849

7.  Treatment of Neuromyelitis Optica Spectrum Disorder: Acute, Preventive, and Symptomatic.

Authors:  Remi A Kessler; Maureen A Mealy; Michael Levy
Journal:  Curr Treat Options Neurol       Date:  2016-01       Impact factor: 3.598

Review 8.  Pain in neuromyelitis optica--prevalence, pathogenesis and therapy.

Authors:  Monika Bradl; Yoko Kanamori; Ichiro Nakashima; Tatsuro Misu; Kazuo Fujihara; Hans Lassmann; Jürgen Sandkühler
Journal:  Nat Rev Neurol       Date:  2014-07-29       Impact factor: 42.937

9.  Assessment of Patients with Neuromyelitis Optica Spectrum Disorder Using the EQ-5D.

Authors:  Maureen A Mealy; Audra Boscoe; Jaime Caro; Michael Levy
Journal:  Int J MS Care       Date:  2019 May-Jun

10.  Development of a patient-centred conceptual framework of health-related quality of life in neuromyelitis optica: a qualitative study.

Authors:  Abigail M Methley; Kerry Mutch; Perry Moore; Anu Jacob
Journal:  Health Expect       Date:  2015-11-24       Impact factor: 3.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.